About Jonathan Bromberg
Form D filings for Nodal Therapeutics in 2024 list Jonathan Bromberg as executive officer.
Jonathan Bromberg first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Bromberg in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Bromberg works with at each company, as listed on that company's latest Form D.
Nodal Therapeutics, Inc. · Form D/A, Oct 29, 2024
CJ
Christopher Jewell
Chief Executive Officer and director